Mohammad Rizki Fadhil Pratama ORCID logo Verified

Universitas Muhammadiyah Palangkaraya
ORCID logo 0000-0002-0727-4392

Mohammad Rizki Fadhil Pratama is a lecturer at the Department of Pharmacy, Universitas Muhammadiyah Palangkaraya, Indonesia, as well as a doctoral student in Pharmaceutical Sciences, Universitas Airlangga, Indonesia. His research interest is the discovery of new medicinal compounds with lead compounds derived from medicinal plant metabolites from Indonesia, using medicinal chemistry and bioinformatics approaches. His dissertation research is on developing benzoyl pinostrobin derivatives from Boesenbergia pandurata as an anti-breast cancer, under Professor Dr. Siswandono and Hadi Poerwono Ph.D.'s supervision. He participates in various scientific associations such as the Indonesian Society for Cancer Chemoprevention and the Indonesian Pharmacists Association. In addition to the pharmaceutical science, he also plays an active role in the field of scientific publications by joining several organizations, such as the Indonesian Association of Scientific Journal Editors, Indonesian Journal Volunteer Association, Council of Asian Science Editors, Asian Council of Science Editors, and others. He currently serves as Editor-in-Chief of two international journals: Borneo Journal of Pharmacy and Journal of Molecular Docking. He also plays an active role as associate editor and reviewer of dozens of scientific journals from Indonesia and abroad.

Last synced: 2 years ago

Publications
38
Fundings
1
Peer Reviews
38

Universitas Muhammadiyah Palangkaraya

Palangka Raya, Central Kalimantan, ID

01 August 2015 - Present | Assistant Professor (Pharmacy)


Source : Mohammad Rizki Fadhil Pratama

Rohto Laboratories Indonesia

Bandung, West Java, ID

01 November 2012 - 01 February 2013 | Staff (Quality Assurance)


Source : Mohammad Rizki Fadhil Pratama

Educations

Universitas Airlangga Fakultas Farmasi

Surabaya , East Java , ID

01 March 2019 - Present | Doctor of Pharmacy (Pharmacy)

Education


Source : Mohammad Rizki Fadhil Pratama

Institut Teknologi Bandung Sekolah Farmasi

Bandung , West Java , ID

01 August 2013 - 30 June 2015 | Master (Pharmaceutical Sciences)

Education


Source : Mohammad Rizki Fadhil Pratama

Institut Teknologi Bandung Sekolah Farmasi

Bandung , West Java , ID

24 August 2011 - 10 October 2012 | Pharmacist (Pharmacy)

Education


Source : Mohammad Rizki Fadhil Pratama

Universitas Lambung Mangkurat Fakultas Matematika dan Ilmu Pengetahuan Alam

Banjarmasin , South Kalimantan , ID

01 August 2007 - 05 August 2011 | Bachelor of Parmacy (Pharmacy)

Education


Source : Mohammad Rizki Fadhil Pratama

Qualifications

Universitas Muhammadiyah Palangkaraya

Palangka Raya , ID

01 August 2015 - Present | Assistant Professor (Pharmacy)

Qualification


Source : Mohammad Rizki Fadhil Pratama

Ikatan Apoteker Indonesia

Palangka Raya , Central Kalimantan , ID

13 September 2012 - Present | Pharmacist

Qualification


Source : Mohammad Rizki Fadhil Pratama

Invited Positions

Relawan Jurnal Indonesia

Bantul , Yogyakarta , ID

01 April 2021 - Present | Supervisor 1000 Jurnal Terakreditasi

Invited position


Source : Mohammad Rizki Fadhil Pratama

Distinctions

Universitas Muhammadiyah Palangka Raya

Palangka Raya , Central Kalimantan , ID

01 October 2017 - Present | Pegawai Terbaik Universitas Muhammadiyah Palangkaraya Tahun 2017 (Pharmacy)

Distinction


Source : Mohammad Rizki Fadhil Pratama

Memberships

Council of Asian Science Editor

Seoul , KR

15 May 2020 - Present | Member

Membership


Source : Mohammad Rizki Fadhil Pratama

Ikatan Apoteker Indonesia

Palangka Raya , Central Kalimantan , ID

13 September 2015 - Present | Pharmacist (Pharmacy)

Membership


Source : Mohammad Rizki Fadhil Pratama

Services

Relawan Jurnal Indonesia

Bantul , Yogyakarta , ID

30 June 2019 - Present | Tutor

Service


Source : Mohammad Rizki Fadhil Pratama

Bioactive Compounds from Mangosteen (Garcinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARSCoV- 2: An In Silico Approach

ANM Ansori , VD Kharisma , AA Parikesit , FA Dian , M Rebezov , P Scherbakov , P Burkov , G Zhdanova , A Mikhalev , Y Antonius , MRF Pratama , NI Sumantri , TH Sucipto , R Zainul

February 2022

DOI : 10.5530/pj.2022.14.12


Synthesis, Antibacterial Activity, and Molecular Docking Study of Bispyrazole‐Based Derivatives as Potential Antibacterial Agents

Ghazwan Ali Salman , Dhafer S. Zinad , Ahmed Mahal , Mohammad Rizki Fadhil Pratama , Meiato Duan , Anas Alkhouri , Ahmed Alamiery

January 2022

DOI : 10.1002/slct.202103901


Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation

Aso Hameed Hasan , Sankaranarayanan Murugesan , Syazwani Itri Amran , Subhash Chander , Mohammed M. Alanazi , Taibi Ben Hadda , Sonam Shakya , Mohammad Rizki Fadhil Pratama , Basundhara Das , Subhrajit Biswas , Joazaizulfazli Jamalis

February 2022

DOI : 10.1016/j.bioorg.2021.105572


3D-Molecular Modeling, Antibacterial Activity and Molecular Docking Studies of Some Imidazole Derivatives

Dhafer S. Zinad , Ahmed Mahal , Abdulqader M. A-Qader , Siswandono Siswodihardjo , Mohammad Rizki Fadhil Pratama , Ranjan Mohapatra

August 2020

DOI : 10.21608/ejchem.2020.31043.2662


Medicinal chemistry of oxazines as promising agents in drug discovery

Dhafer S. Zinad , Ahmed Mahal , Ranjan K. Mohapatra , Ashish K. Sarangi , Mohammad Rizki Fadhil Pratama

October 2019

DOI : 10.1111/cbdd.13633


The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm.f) Ness

Sukardiman , Martha Ervina , MohammadRizki Fadhil Pratama , Hadi Poerwono , Siswandono Siswodihardjo

January 2020

DOI : 10.4103/japtr.japtr_84_20


Rambusa (Passiflora foetida L) vs. Free Radicals: In Vitro Study with DPPH Method

Dewi Sari Mulia , Evi Mulyani , Muhammad Ikhwan Rizki , Mohammad Rizki Fadhil Pratama

November 2019

DOI : 10.20527/jps.v6i2.7344


The Antifungal Activity of Artesunate toward Candida albicans: Two Opposite Activities

MOHAMMAD RIZKI FADHIL PRATAMA , , DARYONO HADI TJAHJONO , TUTUS GUSDINAR , ,

January 2019

DOI : 10.5454/mi.13.3.5


Pharmacophore Optimization Of Berberine As HER2 Inhibitor

Mohammad Rizki Fadhil Pratama , Guntur Satrio Pratomo

February 2018

DOI : 10.31001/jfi.v14i2.282


In Silico Analysis of Plantaricin EF that Expressed by Plasmid-Associated Bacteriocin Production Gene of Lactobacillus plantarum IBL-2 for Anti-Candida Agent Potential

Betty Nurhayati , Marlia Singgih Wibowo , Yantyati Widyastuti , Pande Putu Erawijanta , Wahyu Widowati , Mohammad Rizki Fadhi Pratama , Tutus Gusdinar Kartawinat

December 2015

DOI : 10.3923/jm.2015.582.591


In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions

Aso Hameed Hasan , Narmin Hamaamin Hussen , Sonam Shakya , Joazaizulfazli Jamalis , Mohammad Rizki Fadhil Pratama , Subhash Chander , Harsha Kharkwal , Sankaranarayanan Murugesan

July 2022

DOI : 10.1007/s11224-022-01996-y


Molecular Docking and DFT Study of Synthesized Oxazine Derivatives

Dhafer Zinad , Ahmed Mahal , Ghazwan Salman , Omar Shareef , Mohammad Pratama

December 2021

DOI : 10.21608/ejchem.2021.102664.4755


Penelusuran Identitas dan Struktur Kimia Metabolit Sekunder Akar Kuning (Arcangelisia flava) sebagai Antibakteri

Direktorat Jenderal Pendidikan Tinggi (Jakarta , DKI Jakarta )

01 January 2018 - 01 December 2018


Source : Mohammad Rizki Fadhil Pratama